Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel subfamily K member 1 (KCNK1, also known as TWIK-1) is a membrane protein that belongs to the two-pore domain potassium channel (K2P) family. This protein facilitates passive transmembrane potassium transport and contributes to the regulation of the resting membrane potential, particularly in brain astrocytes and neurons. KCNK1 may not form a functional channel as a homodimer but can form heterodimers with other K2P members, contributing to neuronal excitability and kidney function. Its activity is regulated through mechanisms such as sumoylation and intracellular trafficking. There is no well-established therapeutic agent that targets KCNK1 directly, and it is not currently a common biomarker in clinical use.
No drugs known to act directly on KCNK1/TWIK-1 in clinical use; possible modulation by anesthetics and sumoylation, but insufficient evidence of direct targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel subfamily K member 1 (KCNK1 (also called TWIK-1)).